Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1779-58-4

Post Buying Request

1779-58-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1779-58-4 Usage

Chemical Properties

white powder

Uses

(Methoxycarbonylmethyl)triphenylphosphonium bromide is a reactant for the synthesis of GSK-3 inhibitors using the Wittig reaction, substituted furanones for antifungal and cytostatic activities, photochromic dithienylethene derivatives, gem-diiodoalkanes containing allylic alcohols and highly substituted cyclopentenes and brazilanes via Au-catalyzed deoxygenative Nazarov cyclization. As reactant for asymmetric hydrogenation of α,β-unsaturated ester-phosphonates, studies of thermal decomposition of phosphonium alkyl ester salts.

Purification Methods

Wash it with pet ether (b 40-50o), recrystallise it from CHCl3/Et2O and dry it at high vacuum at 65o. [Isler et al. Helv Chim Acta 40 1242 1957, Wittig & Haag Chem Ber 88 1654, 1664 1955, Beilstein 16 IV 981.]

Check Digit Verification of cas no

The CAS Registry Mumber 1779-58-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,7,7 and 9 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1779-58:
(6*1)+(5*7)+(4*7)+(3*9)+(2*5)+(1*8)=114
114 % 10 = 4
So 1779-58-4 is a valid CAS Registry Number.
InChI:InChI=1/C21H20O2P.BrH/c1-23-21(22)17-24(18-11-5-2-6-12-18,19-13-7-3-8-14-19)20-15-9-4-10-16-20;/h2-16H,17H2,1H3;1H/q+1;/p-1

1779-58-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (M1326)  Methoxycarbonylmethyl(triphenyl)phosphonium Bromide  >97.0%(HPLC)(T)

  • 1779-58-4

  • 25g

  • 450.00CNY

  • Detail
  • Alfa Aesar

  • (A16301)  (Methoxycarbonylmethyl)triphenylphosphonium bromide, 98+%   

  • 1779-58-4

  • 25g

  • 284.0CNY

  • Detail
  • Alfa Aesar

  • (A16301)  (Methoxycarbonylmethyl)triphenylphosphonium bromide, 98+%   

  • 1779-58-4

  • 100g

  • 828.0CNY

  • Detail
  • Alfa Aesar

  • (A16301)  (Methoxycarbonylmethyl)triphenylphosphonium bromide, 98+%   

  • 1779-58-4

  • 500g

  • 2804.0CNY

  • Detail
  • Aldrich

  • (259063)  (Methoxycarbonylmethyl)triphenylphosphoniumbromide  98%

  • 1779-58-4

  • 259063-50G

  • CNY

  • Detail
  • Aldrich

  • (259063)  (Methoxycarbonylmethyl)triphenylphosphoniumbromide  98%

  • 1779-58-4

  • 259063-250G

  • 2,390.31CNY

  • Detail

1779-58-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name (2-methoxy-2-oxoethyl)-triphenylphosphanium,bromide

1.2 Other means of identification

Product number -
Other names Ph3PCHCO2MeBr

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1779-58-4 SDS

1779-58-4Relevant articles and documents

Cicindeloine from Stenus cicindeloides-isolation, structure elucidation, and total synthesis

Mueller, Tobias,Goehl, Matthias,Lusebrink, Inka,Dettner, Konrad,Seifert, Karlheinz

, p. 2323 - 2330 (2012)

The new piperideine alkaloid cicindeloine (3) was isolated from the pygidial glands of the beetles Stenus cicindeloides and Stenus solutus. The structure and absolute configuration of 3 were elucidated by NMR spectroscopy and asymmetric synthesis, respect

Booth,Hargreaves

, p. 308 (1970)

Organocatalyzed [2+2] Cycloaddition Reactions between Quinone Imine Ketals and Allenoates

Liu, Teng,He, Chixian,Wang, Fan,Shen, Xiang,Li, Yongqin,Lang, Man,Li, Guijun,Huang, Chao,Cheng, Feixiang

, p. 518 - 526 (2020/10/12)

A new cycloaddition reaction of quinone imine ketals (QIKs), which could be utilized to the construction of functionalized azaspirocyclics under mild conditions, is described. This transformation involved a [2+2] cycloaddition reaction between QIKs and allenoates catalyzed by DABCO, and then treatment with 1 N HCl in one-pot. The strategy could provide a practical route to access azetidine-fused spirohexadienones in good to excellent yields and with high E -selectivity.

Substituted dienes prepared from betulinic acid – Synthesis, cytotoxicity, mechanism of action, and pharmacological parameters

?arek, Jan,Benická, Sandra,D?ubák, Petr,Frydrych, Ivo,Gurská, Soňa,Hajdúch, Marián,Kotulová, Jana,Li?ková, Barbora,Olejníková, Denisa,Pokorny, Jan,Urban, Milan

, (2021/07/28)

A set of new substituted dienes were synthesized from betulinic acid by its oxidation to 30-oxobetulinic acid followed by the Wittig reaction. Cytotoxicity of all compounds was tested in vitro in eight cancer cell lines and two noncancer fibroblasts. Almost all dienes were more cytotoxic than betulinic acid. Compounds 4.22, 4.30, 4.33, 4.39 had IC50 below 5 μmol/L; 4.22 and 4.39 were selected for studies of the mechanism of action. Cell cycle analysis revealed an increase in the number of apoptotic cells at 5 × IC50 concentration, where activation of irreversible changes leading to cell death can be expected. Both 4.22 and 4.39 led to the accumulation of cells in the G0/G1 phase with partial inhibition of DNA/RNA synthesis at 1 × IC50 and almost complete inhibition at 5 × IC50. Interestingly, compound 4.39 at 5 × IC50 caused the accumulation of cells in the S phase. Higher concentrations of tested drugs probably inhibit more off-targets than lower concentrations. Mechanisms disrupting cellular metabolism can induce the accumulation of cells in the S phase. Both compounds 4.22 and 4.39 trigger selective apoptosis in cancer cells via intrinsic pathway, which we have demonstrated by changes in the expression of the crucial apoptosis-related protein. Pharmacological parameters of derivative 4.22 were superior to 4.39, therefore 4.22 was the finally selected candidate for the development of anticancer drug.

Enantioselective Allenoate-Claisen Rearrangement Using Chiral Phosphate Catalysts

Ellwart, Mario,Gensch, Tobias,Han, Seo-Jung,Lin, Hsin-Hui,Miró, Javier,Sigman, Matthew S.,Toste, F. Dean

supporting information, p. 6390 - 6399 (2020/04/27)

Herein we report the first highly enantioselective allenoate-Claisen rearrangement using doubly axially chiral phosphate sodium salts as catalysts. This synthetic method provides access to β-amino acid derivatives with vicinal stereocenters in up to 95percent ee. We also investigated the mechanism of enantioinduction by transition state (TS) computations with DFT as well as statistical modeling of the relationship between selectivity and the molecular features of both the catalyst and substrate. The mutual interactions of charge-separated regions in both the zwitterionic intermediate generated by reaction of an amine to the allenoate and the Na+-salt of the chiral phosphate leads to an orientation of the TS in the catalytic pocket that maximizes favorable noncovalent interactions. Crucial arene-arene interactions at the periphery of the catalyst lead to a differentiation of the TS diastereomers. These interactions were interrogated using DFT calculations and validated through statistical modeling of parameters describing noncovalent interactions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1779-58-4